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A B S T R A C T
In recent years, the microbiological safety of powdered infant formula has gained increasing attention due to the
identiﬁcation of contaminating C. sakazakii and its epidemiological link with life-threatening neonatal
infections. Current intervention strategies have fallen short of ensuring the production of infant formula that
is free from C. sakazakii. In this study, we describe the isolation and characterisation of three bacteriophages
(phages) and their application as a phage cocktail to inhibit the growth of C. sakazakii in diﬀerent brands of
infant formula, while also assessing the phages ability to prevent bioﬁlm formation. All three phages, isolated
from slurry, possess a relatively broad host range, veriﬁed by their ability to infect across genera and species.
When all three phages were combined and used as part of a phage cocktail, 73% coverage was obtained across all
Cronobacter strains tested. Optimum thermo-tolerance and pH stability were determined between 4 °C–37 °C,
and pH 6–8, respectively, well within the normal range of application of infant formula. Genome sequencing and
analysis revealed all the phages to be free from lysogenic properties, a trait which renders each favourable for
phage therapy applications. As such, the combined-phage preparation (3 × 108 pfu/mL) was found to possess a
strong bactericidal eﬀect on C. sakazakii/C. sakazakii LUX cells (≤104 cfu/mL), resulting in a signiﬁcant
reduction in cell numbers, to below the limit of detection (< 10 cfu/mL). This was observed following a 20 h
challenge in diﬀerent brands of infant formula, where samples in the absence of the phage cocktail reached
concentrations of ~109 cfu/mL. The phage cocktail also demonstrated promise in preventing the establishment
of bioﬁlm, as bioﬁlm formation could not be detected for up to 48 h post treatment. These results highlight the
potential application of this phage preparation for biocontrol of C. sakazakii contamination in reconstituted
infant formula and also as a preventative agent against bioﬁlm formation.
1. Introduction
Cronobacter spp. (formally Enterobacter sakazakii) consists of a
diverse group of Gram-negative, facultatively anaerobic, motile bacilli
belonging to the Enterobacteriaceae family (Iversen et al., 2007). The
genus comprises seven species: Cronobacter sakazakii, Cronobacter
malonaticus, Cronobacter turicensis, Cronobacter universalis, Cronobacter
muytjensi, Cronobacter dublinensis and Cronobacter condiment (Brady
et al., 2013; Joseph et al., 2012). In recent years, C. sakazakii has
gained signiﬁcant attention as an emerging food-borne pathogen due to
the associated link between infectious disease and the consumption of
contaminated foods, in particular, reconstituted infant milk formula.
While C. sakazakii is responsible for causing severe clinical infections in
immunocompromised individuals of all ages, it is pre-term, low-birth
weight infants who are most at risk (FAO/WHO 2008; Healy et al.,
2010). Clinical symptoms of infection in infants include meningitis,
bacteraemia and severe forms of necrotising enterocolitis, with case
fatality rates ranging between 40 and 80% (Friedemann, 2009). These
high mortality rates and the fact that many survivors are very often left
with chronic neurological and developmental disorders, highlights the
damaging eﬀect this organism has on infant health (Forsythe, 2005; Lai,
2001). Accordingly, The International Commission for Microbiological
Speciﬁcations for Foods has ranked C. sakazakii as a “Severe hazard for
restricted populations, life threatening or substantial chronic sequelae
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of long duration”, placing the organism in the same category as
Clostridium botulinum, Cryptosporidium parvum and Listeria monocyto-
genes (types A and B) (ICMSF, 2002).
C. sakazakii is ubiquitous in nature with many studies indicating
that plant material is its primary niche (in particular vegetables, fruits,
cereals, wheat, rice, herbs and spices). However, other more pertinent
sources also found to harbour this pathogen include powdered infant
formula (PIF) and milk powder manufacturing environments
(Friedemann, 2007; Kandhai et al., 2004).
C. sakazakii possess physiological traits which aﬀords its ability to
survive in such environments and thus permit PIF to serve as a prime
vehicle for transmission to the immunocompromised infant. These traits
include, (1) resistance to desiccation and osmotic stress (Breeuwer
et al., 2003), (2) an extended temperature growth range (Iversen and
Forsythe, 2004), (3) thermo-tolerance compared to other Enterobacter-
iaceae found in PIF (Nazarowec-White and Farber, 1997a, 1997b), and
(4) the ability to form bioﬁlms on a range of diﬀerent materials
including polycarbonate which is often used to make babies bottles
(Iversen and Forsythe, 2004).
PIF is not manufactured as a sterile preparation and hence can
become contaminated with C. sakazakii during production. Although
the organism is eﬀectively inactivated during pasteurisation
(Nazarowec-White and Farber, 1997a, 1997b), contamination is likely
to occur from the addition of non-sterile ingredients during manufac-
ture. Indeed, it has been suggested that PIF ingredients originating from
plant material, which have not been heat treated are a potential source
of C. sakazakii contamination (Healy et al., 2010). Other possible
sources of contamination include the use of non-sterile equipment
during processing or reconstitution, and from temperature abuse of the
reconstituted formula itself (Al-Nabulsi et al., 2009).
Capsular polysaccharides on the outer surface of C. sakazakii cells
play a central role in bioﬁlm formation, giving the organism the ability
to attach and colonise a variety of surfaces including stainless steel,
glass, latex, polycarbonate, silicon and polyvinyl chloride (PVC)
(Iversen et al., 2004). The bacterial cells embedded in a matrix of
exopolymeric substances, are physiologically distinct from their plank-
tonic counterparts. These cells demonstrate changes in growth rate and
gene transcription and often exhibit a signiﬁcantly higher tolerance to
antibiotics (≤1000 times higher) and other sanitising agents. The
presence of persister cells, the reduced metabolic activity present in the
inner layers of the bioﬁlm and the decreased penetration of antibiotics
through the exopolymeric matrix, all contribute to this increased
resistance (Donlan and Costerton, 2002; Keren et al., 2004). As a
result, complete elimination is very often compromised and re-infection
commonly occurs.
Consequently, the microbiological safety of PIF is under continuous
scrutiny as a result of contaminating C. sakazakii and its epidemiolo-
gical link with life-threatening neonatal infections (Forsythe, 2005;
Himelright, 2002; Hunter and Bean, 2013). The destructive economic
impact the pathogen has on healthcare systems and PIF production
facilities due to contaminated product recalls is also apparent (Chenu
and Cox, 2009). Indeed, there is a growing requirement for the
development of new and eﬀective mechanisms to further prevent C.
sakazakii contamination in both food, and the food processing environ-
ment.
Bacteriophages (phages) and their derivatives are well recognised
for their antibacterial properties, demonstrating promise as natural,
safe and eﬀective alternatives for the prevention, treatment and/or
eradication of foodborne pathogens in a range of diﬀerent foods and
food processing environments. These include, decontamination of live-
stock, sanitation of contact surfaces and equipment, in addition to
biocontrol of raw meats, fresh foods and vegetables (Endersen et al.,
2014; Goodridge and Bisha, 2011), cheese (Carlton et al., 2005), ready-
to-eat (RTE) foods (Bigot et al., 2011), skim milk (Ellis et al., 1973;
Endersen et al., 2013), and reconstituted infant formula (Kim et al.,
2007), all of which demonstrate their applicability for use at each stage
of the food production process. ListShield™, approved for use in the US
in 2006 as a processing aid to control Listeria monocytogenes in meat and
poultry products, marked the arrival of the ﬁrst phage-based product to
the commercial marketplace in the Western world (Bren, 2006).
Following this signiﬁcant development, several phage related products
have been approved for use in the US, including preparations active
against the prominent foodborne pathogens, E. coli O157:H7, Salmo-
nella, and additional preparations against L. monocytogenes (Endersen
et al., 2014; Goodridge and Bisha, 2011). The pioneering anti-listeria
phage-based preparation is now registered in Europe as an organic food
additive and has also been approved for use as a food processing aid by
the Food Standards Australia & New Zealand, highlighting the fact that
phage-based preparations are continuing to gain global acceptance as
safe and eﬀective alternatives for the biocontrol of harmful foodborne
pathogens (Fsanz, 2012; Hodgson, 2013).
Here we report the isolation and characterisation of three phages
against the opportunistic, foodborne, infant formula pathogen, C.
sakazakii. In addition, we demonstrate the eﬃcacy of the phages, used
as part of a phage cocktail, at inhibiting the growth of C. sakazakii in
four diﬀerent brands of reconstituted infant milk formula while also
assessing the phages ability to prevent bioﬁlm formation.
2. Materials and methods
2.1. Bacterial strains and growth media
The following strains were used in this study: C. sakazakii ATCC
BAA 894, C. sakazakii ATCC BAA 894 LUX, C. sakazakii DPC 6258, C.
muytjensi ATCC 51329, C. sakazakii ATCC 29004, and C. sakazakii DPC
8155. These were sourced from the Dairy Products Research Centre,
DPC, Moorepark, Fermoy, Co. Cork, Ireland. Strains were stored at
−80 °C and routinely grown on Luria-Bertani (LB) agar, in LB broth
and in some cases supplemented with 1% or 2.5% D-(+)-glucose at
37 °C. HiChrome™ Cronobacter spp. Agar, Modiﬁed (14,763, Sigma
Aldrich) was used for selective growth of C. sakazakii when necessary.
Selective growth of C. sakazakii ATCC BAA 894 LUX was achieved by
the addition of 500 μg/mL erythromycin to LB broth/agar.
2.2. Isolation of phages
Phages were isolated from slurry, sourced from a cattle farmer in
Clonakilty, West Cork, Ireland, using methods described previously
(Carlson, 2005). Brieﬂy, each sample (5 mL) was added to equal
volumes of LB broth (Sigma Aldrich, UK), supplemented with 10 mM
CaCl2 (Sigma Aldrich) and inoculated with a mid-log phase C. sakazakii
ATCC BAA 894 culture. Samples were incubated overnight at 37 °C with
shaking. Samples were centrifuged at 4000g for 15 min to pellet cells
and debris. The supernatant was ﬁltered through a 0.45 μM ﬁlter and
the ﬁltrate was re-enriched with mid-log phage C. sakazakii culture two
more times. The supernatant obtained from the ﬁnal enrichment step
was ﬁlter-sterilised and tested for the presence of viable infective
phages by adding 100 μL of the ﬁltrate to 100 μL of early log phase C.
sakazakii cells in a 5 mL LB 0.4% w/v overlay agar tube tempered to
50 °C and subsequently poured onto the surface of a LB 1.5% w/v agar
plate. Plates were incubated at 37 °C overnight and then examined for
phage plaques.
2.3. Phage puriﬁcation and ampliﬁcation
Presumptive phages were puriﬁed by successive single plaque
isolation and were routinely propagated on C. sakazakii ATCC BAA
894 as previously described (O'Flaherty et al., 2005). Brieﬂy, a single
isolated plaque was aseptically picked from a lawn of C. sakazakii ATCC
BAA 894 on LB agar using a sterile capillary tube and added to 100 μL
of early-log phase culture. The sample was incubated at 37 °C over-
night. The resulting lysate was centrifuged, ﬁlter sterilised and serially
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diluted followed by standard plaque assay on C. sakazakii, as described
previously. Single plaque puriﬁcation was repeated twice, after which
puriﬁed phage was recovered. The phage titre was assessed using a spot
plaque assay method, where 10 μL of serial dilutions of each phage
suspension were spotted onto C. sakazakii seeded indicator plates.
Plates were incubated at 37 °C overnight and spot dilutions were
subsequently examined for the presence of plaques. High titre phage
suspensions were obtained by adding 5 mL of phage buﬀer (50 mM Tris
pH 8, 150 mM NaCl, 10 mM MgCl2, 2 mM CaCl2) to a standard plaque
assay plate revealing conﬂuent lysis. Phages were recovered by
aseptically running sterile hockey sticks across the surface of the agar
plate to physically recover the phages, incubating for 2 h at 37 °C with
shaking. The buﬀer was then recovered from the plate, centrifuged to
pellet debris and ﬁlter sterilised using a 0.45 μm ﬁlter. Again, phage
titres were assessed using a spot plaque assay technique as described
previously. The puriﬁed high-titre phage solutions were stored at 4 °C.
2.4. Phage DNA preparation
Phage DNA isolation and restriction analysis were carried out as
previously described (Kropinski and Clokie, 2009). Brieﬂy, 18 μL of
1 mg/mL DNAse I (Fischer Scientiﬁc, 11873795) and 8 μL of 12.5 mg/
mL RNase A (Sigma-Aldrich) were added to 1.8 mL aliquots of phage
lysate. Samples were mixed and incubated at 37 °C for 30 min in order
to remove host genomic contaminants. Subsequently, 92 μL of 10% SDS
and 18 μL of 10 mg/mL proteinase K (Roche) were added. Following
further 30 min incubation at 65 °C, proteins were removed by two
chloroform steps. Equal volumes of chloroform: isoamyl alcohol: phenol
(24:24:1) (Sigma-Aldrich, Dublin, Ireland) was added, mixed thor-
oughly and centrifuged at 1500g for 5 min (repeated twice). The upper
layer was carefully removed and transferred to a new sterile tube. This
step was repeated using equal volumes of chloroform: isoamyl alcohol
(24:1), centrifuged for 5 min at 6000g. DNA was precipitated from the
sample using 0.3 M Sodium Acetate solution pH 5.2 and 100% ethanol
(2/3 volume of extract) following incubation at room temperature for
20 min. Samples were centrifuged for 20 min at 14000g. The DNA was
washed twice with 70% ethanol. DNA pellets were dried in a Rotovap
(DNA speed Vac, DNA 110, Savant, Instruments. Inc. Holbrook, NY) on
low power for 2–3 min to remove existing ethanol. DNA was re-
suspended in TE buﬀer pH 7.4 and dissolved at 55 °C for 1–2 h. The
quality and quantity of DNA was assessed by use of Nanodrop spectro-
photometer (Nanodrop ND 1000) and running DNA on an agarose gel
by electrophoresis followed by visualisation.
2.5. Genome sequencing and annotation
Phage DNA was sequenced with the Illumina MiSeq system at VIB
Nucleomics Core, Belgium for phages vB_CsaM_leB and vB_CsaM_leN
and at the University of Liverpool, Centre for Genomic Research, UK for
phage vB_CsaM_leE (herein referred to as leB, leN, and leE, respec-
tively). Libraries for phage leB and leN were created with a custom
NEBNext® Ultra™ DNA Kit and for phage leE the TruSeq DNA Nano LT
library Sample Preparation Kit was used. The quality of each library
preparation was assessed using the Agilent Bioanalyzer and Qubit
measurements before being sequenced with paired end reads of
2 × 250 bp for phage leE and 2 × 150 bp for phage leB and leN.
Reads were assembled for phage leB and leN with the CLC Bio
Genomics Workbench v7.0 (Aarhus, Denmark) and for phage leE with
the Spades genome assembler v.3.10 (St. Petersburg, Russia). Contigs
were resolved with average coverage of 964×, 2,182× and 2030× for
phages leB, leN and leE, respectively. Open reading frames (ORFs)
encoding potential proteins were predicted with Glimmer (http://www.
ncbi.nlm.nih.gov/genomes/MICROBES/glimmer_3.cgi) (Delcher et al.,
1999) and GenemarkS (http://exon.gatech.edu/genemark/genemarks.
cgi) (Besemer et al., 2001). Possible functions of these proteins were
predicted with BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.
cgi?PAGE=Proteins) with tRNA genes being predicted with ARAGORN
(http://130.235.46.10/ARAGORN/) (Laslett and Canback, 2004). Lin-
ear genome map comparison of the phages was created using Easyﬁg
(Sullivan et al., 2011) with comparison of genome sequences utilising
TBLASTX. Coregenes (Turner et al., 2013) was used for total proteome
comparisons between phages leB, leE, and leN to Enterobacteria phage
T4 (BLASTP threshold was set at 75%) with PHACTs being used to
predict the lifestyles of phages (http://www.phantome.org/PHACTS/
index.php) (McNair et al., 2012).
2.6. Accession numbers
The genomes of all three phages were submitted to Genbank under
accession numbers KX443552, KX431559 B and KX431560 for phage
leE, leB and leN, respectively.
2.7. Electron microscopy
Transmission electron microscopy (TEM) was performed as de-
scribed previously (Kelly et al., 2012b, Sambrook and Russell, 2006).
Brieﬂy, a puriﬁed phage stock was prepared using CsCl2 gradient to
achieve a titre in excess of 108 pfu/mL. The sample was negatively
stained with 2% (w/v) uranyl acetate on freshly prepared carbon ﬁlms.
Grids were analysed using a Tecnai 10 transmission electron micro-
scope (FEI Company, Eindhoven, the Netherlands) at an acceleration
voltage of 80 kV. Micrographs were taken with a MegaView G2 CCD-
camera (EMSIS, Münster, Germany).
2.8. Host range proﬁles of phages leB, leE, and leN
The host range of each phage was examined against 21 diﬀerent
Cronobacter/Enterobacter strains, many of clinical origin, which were
sourced from the Dairy Products Research Centre, DPC, Moorepark,
Fermoy, Co. Cork, Ireland. Host range was determined by standard
plaque assay technique as described previously (O'Flaherty et al.,
2005).
2.9. Eﬀect of thermal treatment on phage infectivity
For each phage, 3 × 250 μL phage suspensions (~1.0 × 108 pfu/
mL) were each placed either in the fridge at 4 °C or in water baths set to
37 °C, 45 °C, 55 °C, 60 °C, 72 °C and 90 °C respectively. Following 1 h
incubation, 10 μL volumes of serially diluted samples were spotted on
C. sakazakii ATCC BAA 894 seeded agar. Plates were left to dry and
placed in the incubator at 37 °C overnight. A thermocouple (Kane-May
KM330, Inlec, UK) was placed in a control tube containing 250 μL of
phage buﬀer to ensure the desired temperature of the phage suspension
was achieved for each experiment.
2.10. Eﬀect of pH on phage infectivity
For each phage, 3 × 250 μL aliquots of each phage suspension
(~1.0 × 108 pfu/mL) were exposed to diﬀerent pH values ranging
from pH 2.0 to pH 10.0. Phages were suspended in MP buﬀer [50 mM
Tris pH 8, 150 mM NaCl, 10 mM MgCl2, 2 mM CaCl2], which had been
adjusted to desired pH values of 2.0, 4.0, 6.0, 7.0, 8.0, and 10.0,
respectively. The samples was incubated at 37 °C for 1 h, serially
diluted and spotted (10 μL) onto C. sakazakii ATCC BAA 894 seeded
agar. Plates were left to dry and the plates were incubated at 37 °C
overnight.
2.11. Preparation of phage cocktail
The phage cocktail was prepared by combining equal volumes of
each individual puriﬁed phage solution at ~109 pfu/mL. The high titre
phage preparation was stored at 4 °C until needed.
L. Endersen et al. International Journal of Food Microbiology 253 (2017) 1–11
3
2.12. Investigation of the antibacterial potential of the three phage cocktail
against C. Sakazakii ATCC BAA 894 in four diﬀerent brands of
reconstituted infant milk formula
The three phage cocktail (~3 × 108 pfu/mL) was inoculated into
each of the four reconstituted infant milk formulae containing
~1 × 104 cfu/mL of C. sakazakii ATCC BAA 894 to a ﬁnal volume of
10 mL, and incubated with shaking at 37 °C for 20 h. Standard plate
counts were performed on HiChrome™ Cronobacter spp. agar every 2 h
over the 20 h period to quantify surviving cells. This was achieved by
setting up a staggered experiment 12 h apart to account for the hours
that could not be monitored during the night. PIF was prepared
aseptically using sterile water (10% w/v) and mixed to ensure homo-
geneity. Positive controls were represented as samples containing the
inoculated culture at ~1 × 104 cfu/mL +MP buﬀer only. Negative
controls were represented as samples containing reconstituted infant
formula only. All experiments were performed in triplicate and
bacterial concentrations were expressed as mean cfu/mL counts and
standard deviation. In addition, parallel experiments were performed
using a LUX labelled C. sakazakii ATCC BAA 894 strain supplemented
with 500 μg/mL erythromycin in a microtitre plate assay and lumines-
cence was monitored using the in vivo IVIS Imaging System (Xenogen
Inc).
2.13. Bioﬁlm formation
Static microtitre plate assays based on previous studies (Cerca et al.,
2007) were used to investigate bioﬁlm formation but with modiﬁca-
tions. Brieﬂy, an overnight pure culture of the following strains (C.
sakazakii ATCC BAA 894, C. sakazakii ATCC 29004, C. sakazakii DPC
6528, C. sakazakii DPC 8155 and C. muytjensi ATCC 51329) were each
suspended in LB broth to an optical density equivalent of 0.5 McFarland
units. A selection of diﬀerent broths (TSB, BHI and LB) supplemented
with 1% and 2.5% D-(+)-glucose and four diﬀerent brands of infant
formula were tested for their ability to aid in bioﬁlm formation. Cells
were subsequently diluted into the appropriate solution to give a
starting inoculum of ~1 × 104 cfu/mL. 200 μL of the test sample
(BHIglucose(g), LBg, TSBg or PIF) containing the culture was added
to a sterile 96 well plate. 200 μL of test media alone was added as a
negative control. All wells were seeded in triplicate. Microtitre plates
were incubated at 37 °C for 48 h to allow bioﬁlm formation. Following
incubation, media was removed and wells were washed three times
with 200 μL of saline (Ringer's) solution using a multichannel pipette
(Gilson) to remove media and planktonic cells. Microtitre plates were
placed in a 50 °C incubator in an inverted position and allowed to dry
for 1 h. Formed bioﬁlms were stained with 200 μL of 1% crystal violet
solution (Sigma Aldrich, UK) for 10 min at room temperature. The wells
were washed to remove excess dye and left to dry before visually
comparing the intensity of staining in the wells.
2.14. Bioﬁlm prevention with phage cocktail
Following the identiﬁcation of two C. sakazakii strains (C. sakazakii
ATCC BAA 894, and C. sakazakii DPC 6528) that were capable of
forming strong bioﬁlms when grown in diﬀerent types of infant formula
(outlined above, 2.13.), the ability of the phage cocktail to prevent
bioﬁlm formation by these strains was investigated using a plate
staining and live cell count assay.
2.14.1. Plate staining assay
The plate staining assay was performed as per the bioﬁlm formation
method described above with the following adjustments. At the start of
the assay, 50 μL of the phage cocktail (~3 × 108 pfu/mL) was added to
200 μL of C. sakazakii culture in one set of wells in the microtitre plate,
while 50 μL of MP buﬀer was added to a second set of wells also
containing 200 μL of C. sakazakii culture. PIF alone was used as a
negative control. The plates were incubated at 37 °C for 48 h, after
which the media was poured oﬀ and bioﬁlms were stained as described
above. The stain was removed and the wells were washed gently. The
plates were left to dry, after which 30% glacial acetic acid was added to
solubilise the stain. The bioﬁlm prevention ability of the phage cocktail
was assessed by examining the optical density of the wells spectro-
photometrically at OD590nm.
2.14.2. Live cell count assay
The live cell count assay was performed as per the plate staining
method with the following modiﬁcations. At the end of the 48 h
incubation period, the media was removed and bioﬁlms were washed
three times with ringers to remove media and planktonic cells. Bioﬁlms
were resuspended by mechanical scraping in 100 μL of saline solution
(Ringer's) and immediately diluted and plated on to HiChrome™
Cronobacter spp. agar plates to determine cfu/mL counts.
3. Results
3.1. Phage isolation and morphology
Following routine enrichments with the host bacterial strain C.
sakazakii ATCC BAA 894, phage leB, leE and leN were isolated from
slurry samples obtained from a cattle farmer in Clonakilty, Co. Cork,
Ireland. All three phages formed clear plaques on the host strain
following overnight incubation at 37 °C. Plaque size ranged from
2.0 mm to 4.5 mm in diameter on 0.4% semi-solid agar. Each phage
was puriﬁed by successive single plaque isolation and propagation on
the host strain. High titre phage suspensions of ~109 pfu/mL, were
recovered from LB agar plates using 5 ml of MP buﬀer and stored at 4 °C
until needed. Morphological characterisation of phages using TEM
indicated that each belonged to the family Myoviridae (Fig. 1). The
micrographs revealed phage leB, leE, and leN, to have moderately
Fig. 1. Electron micrographs of leB (a), leN (b), and of four phage particles of leE (c), with either extended or contracted (right) tail sheaths. Structural details: collar ( ), tail ﬁbers folded
upwards along the tail sheath ( ), extended tail ﬁbers with typical knee-like hinges (↑), baseplates (►). Uranyl acetate (2%) was used to stain the phages for transmission electron
microscopy.
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elongated heads accompanied by contractile tails, indicating that each
belongs to the family Myoviridae, subtype A2 (Ackermann, 2001).
Phage dimensions are represented in Table 1.
3.2. Results from genome sequencing and annotation
Through sequencing, genomes with sizes of 177,907 bp, 181,570 bp
and 179,516 bp were obtained for phages leB, leE and leN, respectively,
with a G + C% content of 45%. Following bioinformatic annotation a
total number of 281 ORFs, 284 ORFs and 286 ORFs were predicted for
phages leB, leE and leN, respectively, with it being possible to annotate
about 40% (107 ORFs, 111 ORFs and 109 ORFs for leB, leE and leN,
respectively) of their ORFs with a possible function (Supplementary
Table 1). Additionally, one tRNA gene for glycine was predicted to be
present in the genomes of all three phages (see supplemental data).
The genomes of these phage were found to be highly similar to each
other (99% identity with 94–99% coverage) with their closest known
relatives at the nucleotide level being found to be T4 like phages
Cronobacter phage GAP161 [JN882287.1] and Citrobacter phage
Margaery [KT381880.1] (98–99% identity with 92–97% coverage).
At the proteomic level phages leB, leE and leN were found to have
strong homology with Enterobacteria phage T4 [NC_00866] (Fig. 2),
with phage leB sharing 116 homologs and phages leE and leN sharing
117 homologs with that of T4..It has been suggested that phages which
share more> 40% of their proteins fall within phage genus boundaries
(Lavigne et al., 2009). As these phages were found to share> 40% of
their gene products they could be placed within the genus T4 virus.
PHACTs software conﬁdently predicted that all these phages had
lytic lifestyles, with average probability values exceeded 0.5 for phages
leB (0.658), leE(0.663) and leN(0.659). Consistent with this prediction
was that genes for integrases, excisionases or phage repressors were not
identiﬁed in their genomes. Furthermore, no genes for toxins were
detected.
3.3. Phage host range
Host range results revealed that our phages infected 12 (leB), 12
(leE) and 13 (leN) of the 21 strains tested. All phages appeared to
predominantly infect strains within the C. sakazakii species possessing
the ability to plaque and lyse 10 (leB), 10 (leE) and 11 (leN) of 15C.
sakazakii strains tested. In addition, as evidenced by the presence of
plaques, all three phages were capable of infecting across genera and
species, lysing C. muytjensi strain ATCC 51329 and E. cloacae strain
NCTC 11933. However, when tested against other Enterobacter/
Cronobacter species (E. gergorviae NCTC 11431, E. cloacae NCTC
11590, C. malonaticus DPC 6531 and E. aerogenes NCTC 10006), lysis
was not evident. The combination of all three phages resulted in 73%
coverage across the Cronobacter strains tested (Table 2).
3.4. Eﬀect of temperature and pH on phage infectivity
All phages were tested for their ability to retain infectivity following
exposure to a range of diﬀerent temperature extremes. In general, it was
observed that all phage retained infectivity between 4 and 50 °C. While
a ~2.5 log reduction in titre was observed for phage leN following 1 h
exposure to 50 °C, the titres of phage leB and leE were reduced by ≤6
logs during this temperature challenge. No viable phages could be
recovered from the lysates exposed for 1 h to 60 °C, 72 °C or 90 °C
(Fig. 3A).
The eﬀect of pH on phage infectivity was investigated by exposing
phage leB, leE and leN to a range of acidic, neutral and basic
environments for 1 h. In general, all three phages retained activity
over pH 6 to pH 10. However, when exposed pH 10 for 1 h, a 5 log, 3.5
log and 6 log reduction in phage titre was observed for phages leB, leE,
and leN, respectively. No viable phages could be recovered from lysates
following exposure to both pH 2 and pH 4 for 1 h (Fig. 3B).
Table 1
Phage dimensions.
Phage Head (nm) Tail length (nm) incl. collar and baseplate Free tail ﬁbers (nm)
leB 119.4 ± 3.6 × 89.7 ± 3.6 (n= 6) 116.0 ± 1.5 (n= 5) Not visible on micrographs
leE 115.1 ± 3.5 × 90.3 ± 6.9 (n= 15) 113.8 ± 2.0 (n= 11) 111.5 ± 7.4 (n= 15)
leN 113.0 ± 4.1 × 91.9 ± 2.5 (n= 16) 114.6 ± 2.4 (n= 18) 114.0 ± 7.9 (n= 15)
Fig. 2. Linear map comparison of the genomes of Enterobacteria phage T4 and of Cronobacter sakazakii phage leB, leE and leN, created using EasyFig, utilising tBLASTx to make
comparison between genomes. The genome maps are comprised of blue arrows indicating locations of genes among the diﬀerent phage genomes and lines between genome maps indicate
level of homology. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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3.5. Investigation of the antibacterial potential of the three phage cocktail
against C. sakazakii ATCC BAA 894 in four diﬀerent brands of reconstituted
infant milk formula
Cronobacter phages leB, leE, and leN were combined as part of a
phage cocktail (~3 × 108 pfu/mL) to assess their ability to inhibit the
growth of Cronobacter sakazakii ATCC BAA 894 in four diﬀerent brands
of infant formula. Bacterial counts of ~1 × 104 cfu/mL were used for
each biocontrol experiment, as this bacteria:phage concentration ratio
was determined as the maximum inhibitory limit to successfully
prevent outgrowth of C. sakazakii following the 20 h challenge. This
contaminating concentration of cells is well in excess of the expected
levels of C. sakazakii contamination typically found in reconstituted
powdered infant formula (< 1 cell/100 g of PIF) (van Acker et al.,
2001) and hence represents a clear indication of phage biocontrol
potential. Following a 5 h incubation period, C. sakazakii concentra-
tions were reduced to below the detection limit (< 10 cfu/mL) in
samples challenged with the phage cocktail. This level of inactivation
was maintained over the 20 h challenge, where samples in the absence
of the phage cocktail had reached bacterial concentrations in excess of
109 cfu/mL (Fig. 4). Parallel experiments, where the LUX labelled C.
sakazakii ATCC BAA 894 strain was employed to monitor cell viability,
gave a similar result. Luminescence could not be detected from the
wells challenged with the phage cocktail over the 20 h period, where
signiﬁcant relative light units (RLUs) were detected in the wells
containing C. sakazakii LUX cells + MP buﬀer only (Fig. 5). At the
end of the assay all wells were serially diluted and plated to determine
the number of viable cells present in the sample. While the wells
containing C. sakazakii LUX strain alone had reached a concentration of
~109 cfu/mL, bacterial concentrations were reduced below the limit of
detection (< 10 cfu/mL) in the wells challenged with the phage
cocktail.
3.6. Bioﬁlm formation
Static microtitre plate assays were used to investigate bioﬁlm
formation by selected Cronobacter strains. Strain selection was depen-
dant on individual phage infection proﬁles when tested against the 21
Cronobacter strains. Based on phage susceptibility testing (Table 2), ﬁve
strains were selected for bioﬁlm formation assessment. Bioﬁlm forma-
tion experiments were performed in BHI, TSB and LB broths, supple-
mented with 1% and 2.5% glucose and also in four diﬀerent brands of
Table 2
Host range of Cronobacter phages leB, leE, and leN, where phage lysis is represented in cfu/mL. (−) denotes – no lytic activity. Strains were obtained from the Dairy Products Research
Centre, DPC, Moorepark, Fermoy, Co. Cork, Ireland.
Strain name Origin Phage lysis (cfu/mL)
leB leE leN
C. sakazakii ATCC BAA 894 Powdered infant formula 1.35E + 08 1.20E + 08 1.01E + 08
C. sakazakii DPC 6529 Tracheal aspirate − − 5.10E + 02
C. sakazakii DPC 6522 Blood 8.00E + 01 1.19E + 02 2.10E + 02
C. sakazakii DPC 6523 Cerebral spinal ﬂuid − − −
C. sakazakii NCT 8155 Tin of dried powdered milk 1.20E + 08 1.17E + 09 1.05E + 09
C. muytjensi ATCC 51329 − 2.20E + 09 1.20E + 08 1.90E + 07
C. sakazakii DPC 6524 Stool − − −
C. sakazakii DSM 4485 Child's throat 7.50E + 05 5.00E + 01 1.70E + 02
C. malonaticus DPC 6531 Brain tumour − − −
C. sakazakii ATCC 29004 − 1.89E + 07 2.70E + 08 4.50E + 08
C. sakazakii DPC 6530 Bronchial alveolar lavage 4.20E + 02 3.30E + 04 6.80E + 04
E. cloacae NCTC 11933 Human/clinical isolate 1.00E + 01 1.57E + 08 1.00E + 02
C. sakazakii DPC 6527 Blood 4.00E + 01 3.10E + 02 2.00E + 01
E. gergorviae NCTC 11431 Human urinary tract − − −
E. cloacae NCTC 11590 − − − −
E. aerogenes NCTC 10006 Sputum − − −
C. sakazakii DPC 6526 Blood 1.10E + 02 1.98E + 09 4.00E + 01
C. sakazakii ATCC 12868 − − − −
C. sakazakii DPC 6528 Cerebral spinal ﬂuid 7.80E + 07 6.50E + 08 8.70E + 07
C. sakazakii DPC6525 Urine − − −
C. sakazakii NCTC 11467 Human throat 1.76E + 08 3.10E + 02 2.00E + 01
Fig. 3. (A) Eﬀect of temperature on phage viability following 1 h exposure to 4 °C, 37 °C, 45 °C, 50 °C, 60 °C, 72 °C, and 90 °C. (■) represent an average of initial phage titres for all three
phages tested. ( ), ( ), and ( ) columns represent phage leB, leE, leN 1 h temperature challenge experiments, respectively. Assays were performed in triplicate and phage titres were
expressed as the mean ± standard deviation. (B) Eﬀect of pH on phage viability following 1 h exposure to acidic and alkaline environments. (■) represent an average of initial phage
titres for all three phages tested. ( ), ( ), and ( ) represent leB, leE, and leN, 1 h pH challenge experiments. Assays were performed in triplicate and phage titres were expressed as the
mean ± standard deviation.
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Fig. 4. Growth inhibition of C. sakazakii ATCC BAA 894 using the phage cocktail in four diﬀerent brands of reconstituted infant milk formula (PIF1, PIF2, PIF3, and PIF4). Dark grey lines
represent C. sakazakii grown in the absence of the phage cocktail. Light grey lines represent C. sakazakii grown in the presence of the phage cocktail (~3 × 108 pfu/mL). Growth
inhibition of C. sakazakii was determined by cfu/mL counts. Assays were performed in triplicate and bacterial concentrations were expressed as the mean ± standard deviation.
Fig. 5. Bioluminescence assay demonstrating the biocontrol potential of the phage cocktail following a 20 h challenge against C. sakazakii ATCC BAA 894 LUX in PIF1 brand of
reconstituted infant milk formula. PIF1 is representative of PIF2, PIF3, and PIF4. Lane 1 contains PIF alone. Lane 2 contains C. sakazakii LUX +MP buﬀer. Lane 3 contains C. sakazakii
LUX + the phage cocktail at ~3 × 108 pfu/mL.
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reconstituted infant milk formulae. Wells were inoculated with the
selected Cronobacter strains and incubated at 37 °C for 48 h, followed by
the addition of a 1% crystal violet stain to allow for direct visualisation
of bioﬁlms. It was found that the ﬁve Cronobacter strains were incapable
of forming bioﬁlms in BHI, TSB and LB alone and when supplemented
with diﬀerent concentrations of glucose (results not shown). However,
C. sakazakii ATCC BAA 894 and C. sakazakii DPC 6528 were found to be
strong bioﬁlm producers when grown in each of the four diﬀerent
brands of PIF tested (Fig. 6).
3.7. Bioﬁlm prevention - plate staining and live cell count assay
The ﬁrst step of bioﬁlm formation is initial attachment of bacteria to
a solid surface. Accordingly, the eﬀect of a high-titre, three-phage
preparation (~3 × 108 pfu/mL) was assessed for its ability to prevent
bioﬁlm formation by C. sakazakii ATCC BAA 894 and C. sakazakii DPC
6528 in diﬀerent brands of infant formula. Static microtitre plate assays
were used and monitored by plate staining and live cell count assays.
Plates were stained following the 48 h bioﬁlm prevention challenge.
The stain was subsequently solubilised and measured at OD590nm to
further assess the ability of the phage cocktail to prevent bioﬁlm
formation. This data is presented in Fig. 7. Results revealed the phage
cocktail to be very eﬀective at preventing bioﬁlm formation, which was
evident when compared to the control wells where strong bioﬁlm
formation was observed. In addition, parallel plate count experiments
were performed in conjunction with the plate staining and solubilisa-
tion assays. Following the 48 h bioﬁlm prevention challenge, bacterial
concentrations were reduced to below the limit of detection (< 10 cfu/
mL) in the wells containing the phage cocktail, when compared to the
control wells, where bacterial growth had reached levels of ~109 cfu/
mL, again conﬁrming the strong anti-bioﬁlm potential of the phage
cocktail against C. sakazakii in diﬀerent brands of infant formula.
Fig. 6. Bioﬁlm formation by Cronobacter spp. after 48 h incubation at 37 °C in diﬀerent brands of reconstituted infant formulae. Conﬁrmation of strong bioﬁlm formation by C. sakazakii
ATCC BAA 894 and C. sakazakii DPC 6528 is indicated by intense crystal violet staining in wells. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
Fig. 7. Bioﬁlm plate staining and solubilisation assays demonstrating the eﬃcacy of the phage cocktail at preventing bioﬁlm formation by C. sakazakii ATCC BAA 894 and C. sakazakii
DPC 6528 following a 48 h challenge. () PIF only, () PIF containing C. sakazakii cells and MP buﬀer, and () PIF containing C. sakazakii cells and the three phage cocktail.
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4. Discussion
Consumption of contaminated reconstituted infant milk formula
and concomitant C. sakazakii infections in infants and neonates has
resulted in international eﬀorts to improve existing pathogen control
processes. Current intervention strategies have fallen short of providing
powdered infant formula that is free from C. sakazakii contamination.
Many novel technologies have been proposed in an eﬀort to address this
problem, some of which include, the use of hot water, gamma
irradiation and high pressure processing to inactivate the pathogen
prior to ingestion (Edelson-Mammel and Buchanan, 2004; Gonzalez
et al., 2006; Lee et al., 2006). The natural biotherapeutic properties of
phages are well recognised throughout the world, with many studies
providing promising evidence of their biocontrol potential against
several leading and emerging foodborne pathogens, while also demon-
strating their suitability for use at each stage of the farm-to-fork
continuum (Endersen et al., 2014; Goodridge and Bisha, 2011).
The rationale and motivation for performing the current study
relates to the aforementioned reconstituted infant milk formula dilem-
ma, and its associated health risks, in addition to the possibility of
employing naturally occurring phages to alleviate this problem. We
describe the isolation and characterisation of three novel Cronobacter
phages and subsequent utilisation of a three phage preparation for
biocontrol of C. sakazakii in diﬀerent brands of infant formula. In
addition to the activity and stability of the phages in infant formula, the
anti-bioﬁlm potential of the phage cocktail was also demonstrated.
Three Cronobacter phages were isolated following routine enrichments
of a variety of diﬀerent environmental samples, including soil, slurry,
activated sludge, river water, moss, grass, and wheat. While multiple
phages were isolated from these sources, three phages which demon-
strated particular promise for use as biocontrol agents against C.
sakazakii were selected for further characterisation. Sewage has been
recognised as a primary niche for many Enterobacteriaceae, so it is not
uncommon that these and other Cronobacter phages were isolated from
eﬄuent environments (Kim et al., 2007; Zuber et al., 2008).
It is well documented that temperate phages from Enterobacteriaceae
are known to harbour important bacterial virulence genes that can be
readily transferred between bacteria. Determining phages to be absent
of lysogenic capabilities is a primary consideration that must be taken
into account if they are to be used in food related applications (Brüssow
et al., 2004; Faruque and Mekalanos, 2012). As these phages have been
determined to have lytic lifestyles and do not possess genes for toxic
proteins they meet the required properties of phage intended for phage
therapy applications. In addition, these phages have been determined to
belong to the phage genus of.T4 virus,.phages from this genus have
been deemed safe for phage therapy applications (Bruttin and Brüssow,
2005; Denou et al., 2009).
Phage susceptibility was assessed using 21 strains from Cronobacter/
Enterobacter genera. The broad host range attributed to phages leB, leE,
and leN correlates well with previous ﬁndings. Loessner et al. (1993),
demonstrated the broad host range of Enterobacter cloncae isolated
phages, which were capable of cross infecting Panteo agglomerans, C.
sakazakii, E. coli and Serratia marcescens (Loessner et al., 1993). In
addition Zuber and co-authors also observed the broad host range
capabilities of ﬁve combined E. sakazakii phages with an infection
proﬁle extending across several genera (Zuber et al., 2008).
Determining the environmental stability of phages considered for
biocontrol in food and the food processing environment is essential.
Common environmental extremes often associated with the food and
food industry include low pH and high temperature pressures.
Establishing the stress limits of each phage, permits appropriate and
optimal application, and more eﬀective biocontrol results overall. Each
of the three phages were challenged for their ability to initiate host
infection following exposure to a range of pH and temperature
extremes. In general, all three phages retained maximum infectivity
between pH 6 and pH 8. These ﬁndings compare well with those
previously demonstrated, where the researchers found that E. coli
phage T7 demonstrated optimum pH stability between pH 6 and pH 8
(Kerby et al., 1949). Similarly, in another study, phage T4 demon-
strated optimum pH stability from pH 6–7.4 (Kłak et al., 2010), whereas
coliphage λ demonstrated very high stability across a wide pH range,
where no signiﬁcant decrease in titre was observed from pH 3–11
(Jepson and March, 2004). Temperature plays a fundamental role in the
survival of phages. Optimal attachment, penetration, multiplication and
the length of the latent period (in the case of temperate phages) are
often dictated by temperature (Nasser and Oman, 1999; Olson et al.,
2004; Yates et al., 1985). Higher than optimal temperatures are thought
to extend the latent period, while lower than optimal temperatures are
often thought to result in a reduced multiplication rate (Tey et al.,
2009). In this current study, phages leB, leE, and leN were found to
retain infectivity from 4 to 50 °C, with optimum infectivity occurring
between 4 and 37 °C. Yang et al. (2010) evaluated the temperature
stability of Acinetobacter phage AB1 which showed a higher tolerance to
extreme temperatures, compared to phage leB, leE, and leN. Phage AB1
was very heat stable at 50 °C and 60 °C, as only a slight drop in phage
titre was observed following a 1 h challenge. At 70 °C a signiﬁcant
number of the phages were inactivated, with only 0.52% of viable
phages remained in the sample following 1 h incubation. Similarly, at
90 °C,> 99% of the phages had lost their infective ability following
15 min exposure to this temperature (Yang et al., 2010). In another
study, the thermo-tolerance of staphylococcal phages was evaluated in
milk. Researchers found that these phages were most stable when
maintained at 4 °C for 8 h, while observing a 20–30% increase in phage
inactivation when challenged at 22 °C and 37 °C, respectively. While
both phages survived very short exposure to high temperature extremes
(72 °C for 15 s), phage titres were reduced below the limit of detection
after 1 min (Garcia et al., 2009).
In recent years, the application of phages for biocontrol of harmful
pathogens in both pre- and postharvest food environments has become
a noteworthy treatment alternative due to the increasing worldwide
problem of antibiotic resistance and the reduction in the development
of novel technologies for pathogen control. In this study, phage
mediated killing and growth inhibition was demonstrated using a
three-phage cocktail against C. sakazakii in four diﬀerent brands of
infant formula. Overall, it was found that the phage cocktail was
eﬀective at reducing contaminating C. sakazakii cells below the limit of
detection (< 10 cfu/mL) when bacterial concentration were used at a
starting concentration of ≤1 × 104 cfu/mL. This bacteria to phage
concentration ratio was the maximum inhibitory limit to successfully
prevent outgrowth of C. sakazakii over the 20 h challenge. It is
interesting to note that despite slight diﬀerences in formula constitu-
tion, the growth rate of C. sakazakii was not aﬀected for all formulas
tested, nor did it impede phage infection. Our biocontrol results were
similar to those outline by Zuber et al. (2008), who found that a high
dose of 108 pfu/mL of phage could eﬀectively sterilise broth contami-
nated with both high (106 cfu/mL) and low (102 cfu/mL) pathogen
counts (Zuber et al., 2008). In addition, Kim et al., 2007 reported
inhibition of C. sakazakii at a range of diﬀerent incubating temperatures
when high titre 109 pfu/mL single phage suspensions were used (Kim
et al., 2007). Both Zuber et al. (2008), and Kim et al. (2007) also
reported that when challenging low numbers of the contaminating
pathogen with a reduced dose of the phage preparation, a delay in
phage replication was evident up until bacterial counts had reached
~104 cfu/mL. Only after crossing this threshold did phage replication
occur but overall did not result in complete sterilisation of the sample.
This would suggest that high concentrations of phage-based prepara-
tions are needed for complete sterilisation of a low quantity of target
cells (Kasman et al., 2002; Weld et al., 2004). It is reported that the
level of C. sakazakii contamination in PIF is very low (< 1 bacterial
cell/100 g) (Holý and Forsythe, 2014), therefore improper handling is
thought to contribute to bacterial growth and subsequent development
of infection among low birth weight infants and neonates. The
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contaminating levels of C. sakazakii used in this study were much
higher than levels typically found in PIF which demonstrates the
eﬃcacy of this phage cocktail for biocontrol of C. sakazakii in
reconstituted infant formula.
Many phage-based intervention strategies have been documented
against bioﬁlm formation (Doolittle et al., 1995; Kelly et al., 2012a).
Bioﬁlms are a signiﬁcant source of repeat contamination in dairy
manufacturing plants, threatening the quality and safety of the
manufactured produce, in addition to causing extensive economic
losses to the food manufacturing industry due to produce recalls and
corrosion of equipment (Gram et al., 2007). In addition, the persistence
of foodborne pathogens, like C. sakazakii, on feeding areas, on the
surfaces of equipment used in formula preparation, and within enteral
feeding tubes, are also thought to contribute to neonatal outbreaks (Kim
et al., 2007). Due to the high fatality rate associated with C. sakazakii
infection among infants and neonates (up to 80%), the destructive
nature of the organism towards survivors, the ability of C. sakazakii to
form bioﬁlms and because of the problems associated with bioﬁlm
treatment and removal, it is clear that bioﬁlm prevention is the
preferable biocontrol option. We evaluated the biocontrol potential of
the phage cocktail for its ability to prevent bioﬁlm formation. Results
indicated that the phage cocktail was very eﬀective in preventing the
establishment of bioﬁlm where bioﬁlm formation could not be detected
for both strains tested for up to 2 days post-treatment. These results
were similar to those outlined by Kelly et al. (2012a, 2012b), who
demonstrated the eﬃcacy of a modiﬁed phage cocktail for the preven-
tion of Staphylococcus aureus bioﬁlm formation. These researchers
observed complete inhibition of bioﬁlm formation over a 48 h time
period (Kelly et al., 2012a). In addition, other studies have described
the use of phages in an attempt to reduce bioﬁlm formation. Hydrogel-
coated catheters were impregnated with phage preparations and
resulted in an approximate 90% reduction in both Proteus mirabilis
and Escherichia coli formed bioﬁlms when compared with un-treated
controls (Carson et al., 2010). The anti-bioﬁlm formation potential
demonstrated by the phage cocktail in this study is promising and may
have potential in future applications as perhaps a stand-alone treatment
or used in conjunction with alternative antibacterials for the control
and/or eradication of C. sakazakii contamination in food and the food
production environment.
5. Conclusion
International eﬀorts to develop novel strategies to improve the
microbiological safety of PIF are ongoing. Although many advances in
pathogen control have been made in recent years, cost and eﬃciency as
well as the safety of preparation and nutritional stability are a problem.
C. sakazakii contamination of PIF still remains an issue for public health
concern. Phages have long been recognised for their inherent ability to
control pathogens in food and food related environments, where other
treatments have failed to do so. More and more, these non-destructive
particles are continually gaining acceptance around the world as a
viable alternative to antibiotics, and other treatment methods following
the rise of multi-drug resistant bacteria. Accordingly, this study has
presented three phages active against the infant formula associated
pathogen, C. sakazakii. The phages were characterised in terms of
temperature and pH stability and were combined to demonstrate the
eﬃcacy of using a three phage cocktail for biocontrol of C. sakazakii in
four diﬀerent brands of infant formula. In addition, their ability to
eﬀectively inhibit bioﬁlm formation was also established. Our results
highlight the promising potential of these phages for biocontrol of C.
sakazakii contamination in infant formula and also as preventative
biotherapeutic agents against bioﬁlm formation. It should be noted that
the isolation of additional phages capable of inactivating more resistant
strains of C. sakazakii is a worthwhile endeavour. While 73% coverage
is impressive, it could certainly be improved upon. Additional studies
are now required in order to further this concept into practical use.
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